Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.

MLA

Caimi, Paolo F., et al. “Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 21, no. 11, Nov. 2015, pp. 1926–31. EBSCOhost, https://doi.org/10.1016/j.bbmt.2015.06.007.

APA

Caimi, P. F., William, B. M., Silva Rondon, C. H., Fu, P., Cooper, B. W., Campagnaro, E. L., Gerson, S. L., Reese-Koc, J., Fox, R., Creger, R. J., de Lima, M., & Lazarus, H. M. (2015). Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 21(11), 1926–1931. https://doi.org/10.1016/j.bbmt.2015.06.007

Chicago

Caimi, Paolo F, Basem M William, Carlos H Silva Rondon, Pingfu Fu, Brenda W Cooper, Erica L Campagnaro, Stanton L Gerson, et al. 2015. “Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 21 (11): 1926–31. doi:10.1016/j.bbmt.2015.06.007.